Aveanna Healthcare Holdings Inc. (AVAH) 10-Year Financial Performance & Capital Metrics

AVAH • • Industrial / General

HealthcareHealthcare FacilitiesHome Health & Hospice CareComprehensive Home Health Providers

AboutAveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Show more

Revenue $2.02B +6.8%
EBITDA $171M +347.9%
Net Income -$11M +91.9%
EPS (Diluted) -0.06 +92.0%
Gross Margin 31.39%
EBITDA Margin 8.44% +319.3%
Operating Margin 6.9% +1521.2%
Net Margin -0.54% +92.4%
ROE -
ROIC 7.99% +1655.9%
Debt/Equity -
Interest Coverage 0.89 +1594.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 84 (top 16%)
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y7.9%

3Y6.44%

TTM11.53%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM114.8%

EPS CAGR

10Y-

5Y-

3Y-

TTM111.44%

ROCE

10Y Avg-3.27%

5Y Avg-5.72%

3Y Avg-8.79%

Latest11.1%

Peer Comparison

Comprehensive Home Health Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.03B	29.90	42.11	27.59%	3.15%	7.78%	2.93%	0.88
CHEChemed Corporation	6.48B	458.93	23.07	7.37%	11.02%	25.89%	5.68%	0.13
EHABEnhabit, Inc.	551.11M	10.89	-3.50	-1.1%	-1.14%	-1.99%	8.6%	1.03
AVAHAveanna Healthcare Holdings Inc.	2.04B	9.76	-172.13	6.82%	0.85%		1.29%

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.25B	1.38B	1.5B	1.68B	1.79B	1.9B	2.02B
Revenue Growth %	-	0.1%	0.08%	0.12%	0.06%	0.06%	0.07%
Cost of Goods Sold+	859.35M	964.81M	1.04B	1.14B	1.23B	1.3B	1.39B
COGS % of Revenue	0.69%	0.7%	0.7%	0.68%	0.69%	0.69%	0.69%
Gross Profit+	394.32M	419.25M	454.51M	542.4M	553.23M	595.43M	635.54M
Gross Margin %	0.31%	0.3%	0.3%	0.32%	0.31%	0.31%	0.31%
Gross Profit Growth %	-	0.06%	0.08%	0.19%	0.02%	0.08%	0.07%
Operating Expenses+	339.71M	380.3M	458M	578.51M	1.2B	587.36M	495.75M
OpEx % of Revenue	0.27%	0.27%	0.31%	0.34%	0.67%	0.31%	0.24%
Selling, General & Admin	321.84M	341M	354.77M	419.64M	483.95M	464.74M	470.47M
SG&A % of Revenue	0.26%	0.25%	0.24%	0.25%	0.27%	0.25%	0.23%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	-13.74M	39.3M	103.23M	158.88M	711.56M	122.62M	25.28M
Operating Income+	39.03M	38.95M	-3.49M	-36.11M	-642.28M	8.07M	139.79M
Operating Margin %	0.03%	0.03%	-0%	-0.02%	-0.36%	0%	0.07%
Operating Income Growth %	-	-0%	-1.09%	-9.36%	-16.79%	1.01%	16.32%
EBITDA+	50.97M	65.97M	26.74M	-722K	-603.46M	38.17M	170.95M
EBITDA Margin %	0.04%	0.05%	0.02%	-0%	-0.34%	0.02%	0.08%
EBITDA Growth %	-	0.29%	-0.59%	-1.03%	-834.82%	1.06%	3.48%
D&A (Non-Cash Add-back)	11.94M	27.01M	30.22M	35.39M	38.82M	30.1M	31.16M
EBIT	25.88M	17.27M	31.25M	-53.34M	-563.87M	9.07M	156.21M
Net Interest Income+	-74.95M	-92.09M	-82.64M	-68.68M	-107.04M	-152.92M	-156.1M
Interest Income	594K	207K	345K	253K	679K	327K	498K
Interest Expense	75.54M	92.3M	82.98M	68.93M	107.72M	153.25M	156.6M
Other Income/Expense	-88.69M	-113.98M	-48.25M	-77.47M	-21.54M	-147.07M	-134.72M
Pretax Income+	-49.66M	-75.03M	-51.73M	-113.58M	-663.81M	-139M	5.07M
Pretax Margin %	-0.04%	-0.05%	-0.03%	-0.07%	-0.37%	-0.07%	0%
Income Tax+	-2.51M	1.49M	5.32M	3.47M	-1.78M	-4.47M	16M
Effective Tax Rate %	0.95%	1.02%	1.1%	1.03%	1%	0.97%	-2.15%
Net Income+	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Net Margin %	-0.04%	-0.06%	-0.04%	-0.07%	-0.37%	-0.07%	-0.01%
Net Income Growth %	-	-0.62%	0.25%	-1.05%	-4.66%	0.8%	0.92%
Net Income (Continuing)	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
EPS (Diluted)+	-0.26	-0.41	-0.31	-0.63	-3.57	-0.71	-0.06
EPS Growth %	-	-0.58%	0.24%	-1.03%	-4.67%	0.8%	0.92%
EPS (Basic)	-0.26	-0.41	-0.31	-0.63	-3.57	-0.71	-0.06
Diluted Shares Outstanding	180.16M	185.9M	185.9M	184.73M	185.55M	189.96M	192.89M
Basic Shares Outstanding	180.16M	185.9M	185.9M	184.73M	185.55M	189.96M	192.89M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	214.93M	186.34M	340.64M	279.21M	269.75M	314.89M	392.67M
Cash & Short-Term Investments	8M	3.33M	137.34M	30.49M	19.22M	43.94M	84.29M
Cash Only	8M	3.33M	137.34M	30.49M	19.22M	43.94M	84.29M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	182.45M	164.3M	180.88M	225.29M	225.63M	245.81M	277.66M
Days Sales Outstanding	53.12	43.33	44.16	48.99	46.07	47.34	50.06
Inventory	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-
Other Current Assets	14.99M	8.56M	11.34M	9.2M	9.81M	9.45M	13.25M
Total Non-Current Assets+	1.34B	1.39B	1.5B	2.06B	1.44B	1.3B	1.27B
Property, Plant & Equipment	27.25M	80.47M	78.87M	83.37M	77.35M	70.05M	58.65M
Fixed Asset Turnover	46.00x	17.20x	18.96x	20.14x	23.11x	27.06x	34.52x
Goodwill	1.23B	1.23B	1.32B	1.84B	1.16B	1.05B	1.05B
Intangible Assets	53.34M	54.3M	73.57M	102.85M	95.86M	94.01M	89.57M
Long-Term Investments	21.74M	0	0	0	0	74.81M	60.63M
Other Non-Current Assets	8.27M	30.35M	31.62M	33.36M	109.11M	4.67M	7.33M
Total Assets+	1.55B	1.58B	1.84B	2.33B	1.71B	1.61B	1.66B
Asset Turnover	0.81x	0.88x	0.81x	0.72x	1.04x	1.17x	1.22x
Asset Growth %	-	0.02%	0.17%	0.27%	-0.27%	-0.06%	0.03%
Total Current Liabilities+	198.36M	168.54M	260.41M	344.83M	326.5M	354.76M	402.17M
Accounts Payable	0	66.42M	56.67M	52.62M	44.62M	30.13M	36.44M
Days Payables Outstanding	-	25.13	19.88	16.91	13.19	8.46	9.57
Short-Term Debt	9.4M	10.09M	12.78M	13.71M	15.38M	168.16M	183.1M
Deferred Revenue (Current)	-1000K	0	1000K	0	0	0	0
Other Current Liabilities	113.97M	20.74M	54.89M	174.37M	181.26M	42.24M	38.65M
Current Ratio	1.08x	1.11x	1.31x	0.81x	0.83x	0.89x	0.98x
Quick Ratio	1.08x	1.11x	1.31x	0.81x	0.83x	0.89x	0.98x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	1.01B	1.14B	1.32B	1.35B	1.39B	1.39B	1.38B
Long-Term Debt	954.73M	1.02B	1.16B	1.23B	1.28B	1.28B	1.27B
Capital Lease Obligations	0	41.22M	40.25M	44.68M	45.82M	39.82M	31.72M
Deferred Tax Liabilities	1.75M	1.75M	27.41M	3.05M	3.84M	4.86M	5.89M
Other Non-Current Liabilities	52.86M	78.42M	85.28M	77.34M	58.69M	64.64M	74.05M
Total Liabilities	1.21B	1.31B	1.58B	1.7B	1.72B	1.74B	1.79B
Total Debt+	952.44M	1.08B	1.23B	1.3B	1.36B	1.5B	1.5B
Net Debt	944.44M	1.08B	1.09B	1.27B	1.34B	1.46B	1.42B
Debt / Equity	2.76x	3.98x	4.60x	2.04x	-	-	-
Debt / EBITDA	18.69x	16.37x	45.94x	-	-	39.28x	8.79x
Net Debt / EBITDA	18.53x	16.32x	40.81x	-	-	38.13x	8.29x
Interest Coverage	0.52x	0.42x	-0.04x	-0.52x	-5.96x	0.05x	0.89x
Total Equity+	344.99M	270.94M	267.17M	637.95M	-4.17M	-127.44M	-122.09M
Equity Growth %	-	-0.21%	-0.01%	1.39%	-1.01%	-29.52%	0.04%
Book Value per Share	1.91	1.46	1.44	3.45	-0.02	-0.67	-0.63
Total Shareholders' Equity	344.99M	270.94M	267.17M	637.95M	-4.17M	-127.44M	-122.09M
Common Stock	66K	1.37M	1.42M	1.85M	1.89M	1.91M	1.93M
Retained Earnings	-323.83M	-400.58M	-457.63M	-574.68M	-1.24B	-1.37B	-1.38B
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	2.13M	1.46M
Minority Interest	0	0	0	0	0	0	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	21.6M	-8.71M	116.62M	-11.35M	-48.4M	22.67M	32.64M
Operating CF Margin %	0.02%	-0.01%	0.08%	-0.01%	-0.03%	0.01%	0.02%
Operating CF Growth %	-	-1.4%	14.38%	-1.1%	-3.26%	1.47%	0.44%
Net Income	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Depreciation & Amortization	11.94M	27.01M	30.22M	35.39M	38.82M	30.1M	31.16M
Stock-Based Compensation	2.12M	1.95M	3.27M	14.43M	15.89M	13.16M	17.46M
Deferred Taxes	-3.63M	-919K	-6.42M	1.31M	-115K	1.01M	1.03M
Other Non-Cash Items	23.56M	26.7M	90.06M	125.89M	601.26M	136.32M	23.87M
Working Capital Changes	34.76M	13.06M	56.54M	-71.33M	-42.22M	-23.4M	-29.97M
Change in Receivables	-7.96M	3.34M	8.56M	-8.81M	-3.23M	-15.32M	-28.64M
Change in Inventory	15.4M	-13.2M	3.48M	-27.06M	0	0	0
Change in Payables	21.51M	19.29M	-6.81M	-11.7M	-3.92M	-13.92M	6.45M
Cash from Investing+	-229.55M	-17.82M	-193.54M	-681.83M	-25.29M	-8.79M	-6.32M
Capital Expenditures	-19.58M	-16.64M	-15.24M	-15.95M	-12.01M	-6.12M	-6.32M
CapEx % of Revenue	0.02%	0.01%	0.01%	0.01%	0.01%	0%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-11.27M	-2.68M	0
Cash from Financing+	204.15M	21.86M	210.94M	586.33M	62.42M	10.85M	14.03M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	0	-47.07M	24.25M	-52.95M	-1.74M	15.63M	13.3M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	2.02M	-25.35M	101.38M	-27.3M	-60.41M	16.56M	26.32M
FCF Margin %	0%	-0.02%	0.07%	-0.02%	-0.03%	0.01%	0.01%
FCF Growth %	-	-13.57%	5%	-1.27%	-1.21%	1.27%	0.59%
FCF per Share	0.01	-0.14	0.55	-0.15	-0.33	0.09	0.14
FCF Conversion (FCF/Net Income)	-0.46x	0.11x	-2.04x	0.10x	0.07x	-0.17x	-2.99x
Interest Paid	62.77M	92.81M	73.05M	58.96M	102.53M	137.85M	152.51M
Taxes Paid	3.15M	1.55M	2.17M	5.28M	1.59M	1.14M	5.71M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-13.67%	-24.85%	-21.2%	-25.86%	-208.92%	-	-
Return on Invested Capital (ROIC)	2.27%	2.22%	-0.19%	-1.66%	-29.75%	0.46%	7.99%
Gross Margin	31.45%	30.29%	30.4%	32.31%	30.95%	31.42%	31.39%
Net Margin	-3.76%	-5.53%	-3.82%	-6.97%	-37.03%	-7.1%	-0.54%
Debt / Equity	2.76x	3.98x	4.60x	2.04x	-	-	-
Interest Coverage	0.52x	0.42x	-0.04x	-0.52x	-5.96x	0.05x	0.89x
FCF Conversion	-0.46x	0.11x	-2.04x	0.10x	0.07x	-0.17x	-2.99x
Revenue Growth	-	10.4%	8.02%	12.27%	6.49%	6.02%	6.82%

Revenue by Segment

	2021	2022	2023	2024
Private Duty Services	1.36B	1.42B	1.52B	1.63B
Private Duty Services Growth	-	4.20%	7.33%	7.62%
Home Health And Hospice	177.27M	232.58M	218.63M	217.81M
Home Health And Hospice Growth	-	31.20%	-6.00%	-0.38%
Medical Solutions	143.23M	139.96M	157.77M	172.09M
Medical Solutions Growth	-	-2.29%	12.73%	9.08%

Frequently Asked Questions

Growth & Financials

Aveanna Healthcare Holdings Inc. (AVAH) reported $2.18B in revenue for fiscal year 2024. This represents a 74% increase from $1.25B in 2018.

Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 6.8% over the past year. This is steady growth.

Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $18.6M in net income for fiscal year 2024 (-0.5% net margin).

Dividend & Returns

Aveanna Healthcare Holdings Inc. (AVAH) generated $78.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Aveanna Healthcare Holdings Inc. (AVAH) 10-Year Financial Performance & Capital Metrics

AVAH • • Industrial / General

HealthcareHealthcare FacilitiesHome Health & Hospice CareComprehensive Home Health Providers

Revenue $2.02B +6.8%
EBITDA $171M +347.9%
Net Income -$11M +91.9%
EPS (Diluted) -0.06 +92.0%
Gross Margin 31.39%
EBITDA Margin 8.44% +319.3%
Operating Margin 6.9% +1521.2%
Net Margin -0.54% +92.4%
ROE -
ROIC 7.99% +1655.9%
Debt/Equity -
Interest Coverage 0.89 +1594.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 84 (top 16%)
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y7.9%

3Y6.44%

TTM11.53%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM114.8%

EPS CAGR

10Y-

5Y-

3Y-

TTM111.44%

ROCE

10Y Avg-3.27%

5Y Avg-5.72%

3Y Avg-8.79%

Latest11.1%

Peer Comparison

Comprehensive Home Health Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.03B	29.90	42.11	27.59%	3.15%	7.78%	2.93%	0.88
CHEChemed Corporation	6.48B	458.93	23.07	7.37%	11.02%	25.89%	5.68%	0.13
EHABEnhabit, Inc.	551.11M	10.89	-3.50	-1.1%	-1.14%	-1.99%	8.6%	1.03
AVAHAveanna Healthcare Holdings Inc.	2.04B	9.76	-172.13	6.82%	0.85%		1.29%

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.25B	1.38B	1.5B	1.68B	1.79B	1.9B	2.02B
Revenue Growth %	-	0.1%	0.08%	0.12%	0.06%	0.06%	0.07%
Cost of Goods Sold+	859.35M	964.81M	1.04B	1.14B	1.23B	1.3B	1.39B
COGS % of Revenue	0.69%	0.7%	0.7%	0.68%	0.69%	0.69%	0.69%
Gross Profit+	394.32M	419.25M	454.51M	542.4M	553.23M	595.43M	635.54M
Gross Margin %	0.31%	0.3%	0.3%	0.32%	0.31%	0.31%	0.31%
Gross Profit Growth %	-	0.06%	0.08%	0.19%	0.02%	0.08%	0.07%
Operating Expenses+	339.71M	380.3M	458M	578.51M	1.2B	587.36M	495.75M
OpEx % of Revenue	0.27%	0.27%	0.31%	0.34%	0.67%	0.31%	0.24%
Selling, General & Admin	321.84M	341M	354.77M	419.64M	483.95M	464.74M	470.47M
SG&A % of Revenue	0.26%	0.25%	0.24%	0.25%	0.27%	0.25%	0.23%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	-13.74M	39.3M	103.23M	158.88M	711.56M	122.62M	25.28M
Operating Income+	39.03M	38.95M	-3.49M	-36.11M	-642.28M	8.07M	139.79M
Operating Margin %	0.03%	0.03%	-0%	-0.02%	-0.36%	0%	0.07%
Operating Income Growth %	-	-0%	-1.09%	-9.36%	-16.79%	1.01%	16.32%
EBITDA+	50.97M	65.97M	26.74M	-722K	-603.46M	38.17M	170.95M
EBITDA Margin %	0.04%	0.05%	0.02%	-0%	-0.34%	0.02%	0.08%
EBITDA Growth %	-	0.29%	-0.59%	-1.03%	-834.82%	1.06%	3.48%
D&A (Non-Cash Add-back)	11.94M	27.01M	30.22M	35.39M	38.82M	30.1M	31.16M
EBIT	25.88M	17.27M	31.25M	-53.34M	-563.87M	9.07M	156.21M
Net Interest Income+	-74.95M	-92.09M	-82.64M	-68.68M	-107.04M	-152.92M	-156.1M
Interest Income	594K	207K	345K	253K	679K	327K	498K
Interest Expense	75.54M	92.3M	82.98M	68.93M	107.72M	153.25M	156.6M
Other Income/Expense	-88.69M	-113.98M	-48.25M	-77.47M	-21.54M	-147.07M	-134.72M
Pretax Income+	-49.66M	-75.03M	-51.73M	-113.58M	-663.81M	-139M	5.07M
Pretax Margin %	-0.04%	-0.05%	-0.03%	-0.07%	-0.37%	-0.07%	0%
Income Tax+	-2.51M	1.49M	5.32M	3.47M	-1.78M	-4.47M	16M
Effective Tax Rate %	0.95%	1.02%	1.1%	1.03%	1%	0.97%	-2.15%
Net Income+	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Net Margin %	-0.04%	-0.06%	-0.04%	-0.07%	-0.37%	-0.07%	-0.01%
Net Income Growth %	-	-0.62%	0.25%	-1.05%	-4.66%	0.8%	0.92%
Net Income (Continuing)	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
EPS (Diluted)+	-0.26	-0.41	-0.31	-0.63	-3.57	-0.71	-0.06
EPS Growth %	-	-0.58%	0.24%	-1.03%	-4.67%	0.8%	0.92%
EPS (Basic)	-0.26	-0.41	-0.31	-0.63	-3.57	-0.71	-0.06
Diluted Shares Outstanding	180.16M	185.9M	185.9M	184.73M	185.55M	189.96M	192.89M
Basic Shares Outstanding	180.16M	185.9M	185.9M	184.73M	185.55M	189.96M	192.89M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	214.93M	186.34M	340.64M	279.21M	269.75M	314.89M	392.67M
Cash & Short-Term Investments	8M	3.33M	137.34M	30.49M	19.22M	43.94M	84.29M
Cash Only	8M	3.33M	137.34M	30.49M	19.22M	43.94M	84.29M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	182.45M	164.3M	180.88M	225.29M	225.63M	245.81M	277.66M
Days Sales Outstanding	53.12	43.33	44.16	48.99	46.07	47.34	50.06
Inventory	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-
Other Current Assets	14.99M	8.56M	11.34M	9.2M	9.81M	9.45M	13.25M
Total Non-Current Assets+	1.34B	1.39B	1.5B	2.06B	1.44B	1.3B	1.27B
Property, Plant & Equipment	27.25M	80.47M	78.87M	83.37M	77.35M	70.05M	58.65M
Fixed Asset Turnover	46.00x	17.20x	18.96x	20.14x	23.11x	27.06x	34.52x
Goodwill	1.23B	1.23B	1.32B	1.84B	1.16B	1.05B	1.05B
Intangible Assets	53.34M	54.3M	73.57M	102.85M	95.86M	94.01M	89.57M
Long-Term Investments	21.74M	0	0	0	0	74.81M	60.63M
Other Non-Current Assets	8.27M	30.35M	31.62M	33.36M	109.11M	4.67M	7.33M
Total Assets+	1.55B	1.58B	1.84B	2.33B	1.71B	1.61B	1.66B
Asset Turnover	0.81x	0.88x	0.81x	0.72x	1.04x	1.17x	1.22x
Asset Growth %	-	0.02%	0.17%	0.27%	-0.27%	-0.06%	0.03%
Total Current Liabilities+	198.36M	168.54M	260.41M	344.83M	326.5M	354.76M	402.17M
Accounts Payable	0	66.42M	56.67M	52.62M	44.62M	30.13M	36.44M
Days Payables Outstanding	-	25.13	19.88	16.91	13.19	8.46	9.57
Short-Term Debt	9.4M	10.09M	12.78M	13.71M	15.38M	168.16M	183.1M
Deferred Revenue (Current)	-1000K	0	1000K	0	0	0	0
Other Current Liabilities	113.97M	20.74M	54.89M	174.37M	181.26M	42.24M	38.65M
Current Ratio	1.08x	1.11x	1.31x	0.81x	0.83x	0.89x	0.98x
Quick Ratio	1.08x	1.11x	1.31x	0.81x	0.83x	0.89x	0.98x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	1.01B	1.14B	1.32B	1.35B	1.39B	1.39B	1.38B
Long-Term Debt	954.73M	1.02B	1.16B	1.23B	1.28B	1.28B	1.27B
Capital Lease Obligations	0	41.22M	40.25M	44.68M	45.82M	39.82M	31.72M
Deferred Tax Liabilities	1.75M	1.75M	27.41M	3.05M	3.84M	4.86M	5.89M
Other Non-Current Liabilities	52.86M	78.42M	85.28M	77.34M	58.69M	64.64M	74.05M
Total Liabilities	1.21B	1.31B	1.58B	1.7B	1.72B	1.74B	1.79B
Total Debt+	952.44M	1.08B	1.23B	1.3B	1.36B	1.5B	1.5B
Net Debt	944.44M	1.08B	1.09B	1.27B	1.34B	1.46B	1.42B
Debt / Equity	2.76x	3.98x	4.60x	2.04x	-	-	-
Debt / EBITDA	18.69x	16.37x	45.94x	-	-	39.28x	8.79x
Net Debt / EBITDA	18.53x	16.32x	40.81x	-	-	38.13x	8.29x
Interest Coverage	0.52x	0.42x	-0.04x	-0.52x	-5.96x	0.05x	0.89x
Total Equity+	344.99M	270.94M	267.17M	637.95M	-4.17M	-127.44M	-122.09M
Equity Growth %	-	-0.21%	-0.01%	1.39%	-1.01%	-29.52%	0.04%
Book Value per Share	1.91	1.46	1.44	3.45	-0.02	-0.67	-0.63
Total Shareholders' Equity	344.99M	270.94M	267.17M	637.95M	-4.17M	-127.44M	-122.09M
Common Stock	66K	1.37M	1.42M	1.85M	1.89M	1.91M	1.93M
Retained Earnings	-323.83M	-400.58M	-457.63M	-574.68M	-1.24B	-1.37B	-1.38B
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	2.13M	1.46M
Minority Interest	0	0	0	0	0	0	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	21.6M	-8.71M	116.62M	-11.35M	-48.4M	22.67M	32.64M
Operating CF Margin %	0.02%	-0.01%	0.08%	-0.01%	-0.03%	0.01%	0.02%
Operating CF Growth %	-	-1.4%	14.38%	-1.1%	-3.26%	1.47%	0.44%
Net Income	-47.15M	-76.52M	-57.05M	-117.04M	-662.03M	-134.52M	-10.93M
Depreciation & Amortization	11.94M	27.01M	30.22M	35.39M	38.82M	30.1M	31.16M
Stock-Based Compensation	2.12M	1.95M	3.27M	14.43M	15.89M	13.16M	17.46M
Deferred Taxes	-3.63M	-919K	-6.42M	1.31M	-115K	1.01M	1.03M
Other Non-Cash Items	23.56M	26.7M	90.06M	125.89M	601.26M	136.32M	23.87M
Working Capital Changes	34.76M	13.06M	56.54M	-71.33M	-42.22M	-23.4M	-29.97M
Change in Receivables	-7.96M	3.34M	8.56M	-8.81M	-3.23M	-15.32M	-28.64M
Change in Inventory	15.4M	-13.2M	3.48M	-27.06M	0	0	0
Change in Payables	21.51M	19.29M	-6.81M	-11.7M	-3.92M	-13.92M	6.45M
Cash from Investing+	-229.55M	-17.82M	-193.54M	-681.83M	-25.29M	-8.79M	-6.32M
Capital Expenditures	-19.58M	-16.64M	-15.24M	-15.95M	-12.01M	-6.12M	-6.32M
CapEx % of Revenue	0.02%	0.01%	0.01%	0.01%	0.01%	0%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-11.27M	-2.68M	0
Cash from Financing+	204.15M	21.86M	210.94M	586.33M	62.42M	10.85M	14.03M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	0	-47.07M	24.25M	-52.95M	-1.74M	15.63M	13.3M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	2.02M	-25.35M	101.38M	-27.3M	-60.41M	16.56M	26.32M
FCF Margin %	0%	-0.02%	0.07%	-0.02%	-0.03%	0.01%	0.01%
FCF Growth %	-	-13.57%	5%	-1.27%	-1.21%	1.27%	0.59%
FCF per Share	0.01	-0.14	0.55	-0.15	-0.33	0.09	0.14
FCF Conversion (FCF/Net Income)	-0.46x	0.11x	-2.04x	0.10x	0.07x	-0.17x	-2.99x
Interest Paid	62.77M	92.81M	73.05M	58.96M	102.53M	137.85M	152.51M
Taxes Paid	3.15M	1.55M	2.17M	5.28M	1.59M	1.14M	5.71M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-13.67%	-24.85%	-21.2%	-25.86%	-208.92%	-	-
Return on Invested Capital (ROIC)	2.27%	2.22%	-0.19%	-1.66%	-29.75%	0.46%	7.99%
Gross Margin	31.45%	30.29%	30.4%	32.31%	30.95%	31.42%	31.39%
Net Margin	-3.76%	-5.53%	-3.82%	-6.97%	-37.03%	-7.1%	-0.54%
Debt / Equity	2.76x	3.98x	4.60x	2.04x	-	-	-
Interest Coverage	0.52x	0.42x	-0.04x	-0.52x	-5.96x	0.05x	0.89x
FCF Conversion	-0.46x	0.11x	-2.04x	0.10x	0.07x	-0.17x	-2.99x
Revenue Growth	-	10.4%	8.02%	12.27%	6.49%	6.02%	6.82%

Revenue by Segment

	2021	2022	2023	2024
Private Duty Services	1.36B	1.42B	1.52B	1.63B
Private Duty Services Growth	-	4.20%	7.33%	7.62%
Home Health And Hospice	177.27M	232.58M	218.63M	217.81M
Home Health And Hospice Growth	-	31.20%	-6.00%	-0.38%
Medical Solutions	143.23M	139.96M	157.77M	172.09M
Medical Solutions Growth	-	-2.29%	12.73%	9.08%

Frequently Asked Questions

Growth & Financials

Aveanna Healthcare Holdings Inc. (AVAH) reported $2.18B in revenue for fiscal year 2024. This represents a 74% increase from $1.25B in 2018.

Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 6.8% over the past year. This is steady growth.

Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $18.6M in net income for fiscal year 2024 (-0.5% net margin).

Dividend & Returns

Aveanna Healthcare Holdings Inc. (AVAH) generated $78.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.